Purchases and Sales Made in Q3 2024 in Catalyst Pharmaceuticals, Inc. (CPRX)
This table provides information about the institutional ownership of Catalyst Pharmaceuticals, Inc. (CPRX) during Q3 2024. The information is specifically focused on institutions that hold shares of CATALYST PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 12, 2024
Q3 2024
|
Pacer Advisors, Inc.
Malvern, PA |
SELL
|
- |
-164K- 5.51% |
$2.48M - $3.49M
|
2.8M
$63.5M
|
|
|
Nov 13, 2024
Q3 2024
|
Globeflex Capital L P
San Diego, CA |
SELL
|
- |
-182K- 79.72% |
$2.77M - $3.89M
|
46.4K
$1.05M
|
|
|
Nov 14, 2024
Q3 2024
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-197K- 39.16% |
$3M - $4.21M
|
306K
$6.94M
|
|
|
Nov 14, 2024
Q3 2024
|
Man Group PLC
London, X0 |
SELL
|
- |
-215K- 45.79% |
$3.27M - $4.59M
|
255K
$5.77M
|
|
|
Nov 14, 2024
Q3 2024
|
Kennedy Capital Management, Inc.
St Louis, MO |
SELL
|
- |
-235K- 18.4% |
$3.57M - $5.01M
|
1.04M
$23.6M
|
|
|
Nov 14, 2024
Q3 2024
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-284K- 21.18% |
$4.32M - $6.07M
|
1.06M
$24M
|
|
|
Nov 14, 2024
Q3 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-348K- 5.77% |
$5.29M - $7.43M
|
5.69M
$129M
|
|
|
Nov 14, 2024
Q3 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-359K- 29.4% |
$5.45M - $7.66M
|
861K
$19.5M
|
|
|
Nov 14, 2024
Q3 2024
|
Opaleye Management Inc.
Boston, MA |
SELL
|
- |
-528K- 82.42% |
$8.01M - $11.3M
|
113K
$2.55M
|
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-558K- 95.67% |
$8.47M - $11.9M
|
25.2K
$572K
|
|
|
Nov 14, 2024
Q3 2024
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-1.82M- 83.44% |
$27.6M - $38.8M
|
360K
$8.16M
|
|
|
Nov 14, 2024
Q3 2024
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
SELL
|
- |
-2.9M- 31.75% |
$44M - $61.9M
|
6.23M
$141M
|